Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$4.17M
22 trades · 7 insiders
Net · 90d
$-4.17M
Insiders on file
45
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Wygant Jonathan | VP, Chief Accounting Officer | 32 | $0 | $1.80M | 2026-10-28 |
| Holstein Jens | Director | 24 | $70.4K | $1.97M | 2026-10-27 |
| EASTHAM KARIN | Director | 71 | $0 | $151.04M | 2026-10-27 |
| Bhanji Muna | Director | 15 | $0 | $670.6K | 2026-10-19 |
| Leite John | Global Chief Commercial Off | 35 | $0 | $2.24M | 2026-09-21 |
| McGuire Annie | SVP, General Counsel | 49 | $0 | $2.88M | 2026-09-04 |
| Chambers Rebecca | Chief Financial Officer | 50 | $0 | $2.98M | 2026-09-04 |
| Febbo Phillip G. | Chief Scientific & Med Officer | 28 | $0 | $2.36M | 2026-09-04 |
| Stapley Marc | Chief Executive Officer, Director | 48 | $979.8K | $11.15M | 2026-09-02 |
| Miller Thomas F. | Director | 3 | $0 | $0 | 2026-06-11 |
| Barr Eliav | Director | 5 | $0 | $0 | 2026-06-11 |
| Shafer David Brent | Director | 3 | $0 | $0 | 2026-06-11 |
| EPSTEIN ROBERT S | Director | 26 | $0 | $2.07M | 2026-06-11 |
| JONES EVAN/ FA | Director | 112 | $0 | $14.24M | 2026-06-11 |
| Haas Kevin Richard | Chief Dev and Tech Officer | 1 | $0 | $0 | 2026-04-10 |
| BISHOP JOHN L | Director | 15 | $0 | $605.0K | 2023-07-18 |
| Anderson Bonnie H | President and CEO | 274 | $54.3K | $26.90M | 2023-06-02 |
| Kennedy Giulia C | Chief Scientific & Med Officer | 211 | $0 | $12.80M | 2022-12-06 |
| GORDON KEVIN K | Director | 17 | $0 | $1.24M | 2022-06-08 |
| Nova Tina Susan | President, CLIA U.S. | 9 | $0 | $0 | 2022-03-03 |
| Alley Beverly Jane | VP, Corporate Controller | 2 | $0 | $0 | 2021-05-17 |
| Ho Mark | Other | 18 | $0 | $624.4K | 2021-03-02 |
| Kennedy Keith | Chief Financial Officer | 61 | $0 | $4.22M | 2021-03-02 |
| Erlinger III James H | Other | 3 | $0 | $0 | 2021-02-26 |
| Hanna John Walter JR | Chief Commercial Officer | 74 | $0 | $6.47M | 2020-12-02 |
| Cohen Fred E | Director | 19 | $0 | $1.07M | 2020-10-19 |
| Hall Christopher M | President and COO | 81 | $0 | $6.84M | 2019-06-03 |
| TREU JESSE I | Director, 10% Owner | 27 | $0 | $26.86M | 2019-03-04 |
| KLEINER PERKINS CAUFIELD & BYERS XII, LLC | 10% Owner | 1 | $0 | $0 | 2017-03-10 |
| Brooks Julie | Exec VP,General Coun,Secretary | 12 | $44.8K | $0 | 2017-03-03 |
| ATWOOD BRIAN G | Director, 10% Owner | 11 | $0 | $0 | 2016-06-20 |
| Guyer Shelly D | Chief Financial Officer | 12 | $0 | $44.6K | 2016-03-01 |
| Powell Duncan Thomas | Principal Accounting Officer | 2 | $0 | $0 | 2015-03-02 |
| Halak Brian K | 10% Owner | 7 | $0 | $0 | 2014-09-10 |
| COLELLA SAMUEL D | Director, 10% Owner | 9 | $0 | $0 | 2014-05-20 |
| BYERS BROOK H | Director, 10% Owner | 5 | $0 | $0 | 2014-05-20 |
| BONDERMAN DAVID | 10% Owner | 4 | $0 | $0 | 2013-11-04 |
| KPCB XII Associates, LLC | 10% Owner | 4 | $0 | $0 | 2013-11-04 |
| Domain Partners VIII, L.P. | 10% Owner | 3 | $0 | $0 | 2013-11-04 |
| DP VIII Associates, L.P. | 10% Owner | 3 | $0 | $0 | 2013-11-04 |
| Versant Venture Capital III, L.P. | 10% Owner | 8 | $0 | $0 | 2013-11-04 |
| SCHOEMAKER KATHLEEN K | 10% Owner | 6 | $0 | $0 | 2013-11-04 |
| DOVEY BRIAN H | 10% Owner | 6 | $0 | $0 | 2013-11-04 |
| VITULLO NICOLE | 10% Owner | 6 | $0 | $0 | 2013-11-04 |
| BLAIR JAMES C | 10% Owner | 6 | $0 | $0 | 2013-11-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2026-10-28 | 2026-10-29 | 1,306 | $50.31 | $65.7K | 41,920 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise deriv | 2026-10-27 | 2026-10-28 | 10,000 | — | $0 | 0 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2026-10-27 | 2026-10-28 | 14,850 | $50.00 | $742.6K | 10,247 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise | 2026-10-27 | 2026-10-28 | 10,000 | $27.01 | $270.1K | 25,097 | SEC↗ |
| Holstein Jens | Director | M Exercise deriv | 2026-10-27 | 2026-10-28 | 7,500 | — | $0 | 20,000 | SEC↗ |
| Holstein Jens | Director | S Sale | 2026-10-27 | 2026-10-28 | 7,500 | $50.00 | $375.0K | 27,471 | SEC↗ |
| Holstein Jens | Director | M Exercise | 2026-10-27 | 2026-10-28 | 7,500 | $35.30 | $264.8K | 34,971 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2026-10-19 | 2026-10-20 | 1,864 | $43.70 | $81.5K | 40,854 | SEC↗ |
| Holstein Jens | Director | M Exercise deriv | 2026-09-24 | 2026-10-28 | 7,500 | — | $0 | 27,500 | SEC↗ |
| Holstein Jens | Director | S Sale | 2026-09-24 | 2026-10-28 | 7,500 | $47.00 | $352.5K | 27,471 | SEC↗ |
| Holstein Jens | Director | M Exercise | 2026-09-24 | 2026-10-28 | 7,500 | $35.30 | $264.8K | 34,971 | SEC↗ |
| Leite John | Global Chief Commercial Off | S Sale | 2026-09-21 | 2026-09-22 | 4,015 | $40.00 | $160.6K | 124,329 | SEC↗ |
| Leite John | Global Chief Commercial Off | S Sale | 2026-09-21 | 2026-09-22 | 4,015 | $40.00 | $160.6K | 124,329 | SEC↗ |
| Holstein Jens | Director | S Sale | 2026-09-14 | 2026-09-16 | 5,000 | $40.95 | $204.8K | 27,471 | SEC↗ |
| Holstein Jens | Director | S Sale | 2026-09-14 | 2026-09-16 | 5,000 | $40.95 | $204.7K | 27,471 | SEC↗ |
| McGuire Annie | EVP, General Counsel | S Sale | 2026-09-04 | 2026-09-04 | 2,154 | $42.79 | $92.2K | 132,260 | SEC↗ |
| McGuire Annie | EVP, General Counsel | S Sale | 2026-09-04 | 2026-09-04 | 1,100 | $43.67 | $48.0K | 131,160 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-09-04 | 2026-09-04 | 2,477 | $42.81 | $106.0K | 167,200 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-09-04 | 2026-09-04 | 1,175 | $43.71 | $51.4K | 166,025 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2026-09-04 | 2026-09-04 | 2,705 | $43.66 | $118.1K | 133,048 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2026-09-04 | 2026-09-04 | 10,405 | $42.89 | $446.3K | 135,753 | SEC↗ |
| McGuire Annie | EVP, General Counsel | S Sale | 2026-09-04 | 2026-09-04 | 1,100 | $43.67 | $48.0K | 131,160 | SEC↗ |
| McGuire Annie | EVP, General Counsel | S Sale | 2026-09-04 | 2026-09-04 | 2,154 | $42.79 | $92.2K | 132,260 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2026-09-04 | 2026-09-04 | 2,705 | $43.66 | $118.1K | 133,048 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2026-09-04 | 2026-09-04 | 10,405 | $42.89 | $446.3K | 135,753 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-09-04 | 2026-09-04 | 1,175 | $43.71 | $51.4K | 166,025 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-09-04 | 2026-09-04 | 2,477 | $42.81 | $106.0K | 167,200 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2026-09-02 | 2026-09-04 | 8,782 | $44.88 | $394.1K | 432,073 | SEC↗ |
| McGuire Annie | EVP, General Counsel | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,215 | $44.88 | $144.3K | 134,414 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,603 | $44.88 | $161.7K | 169,677 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,639 | $44.88 | $163.3K | 146,158 | SEC↗ |
| Leite John | Global Chief Commercial Off | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,961 | $44.88 | $177.8K | 128,344 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2026-09-02 | 2026-09-04 | 1,361 | $44.88 | $61.1K | 43,226 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2026-09-02 | 2026-09-04 | 1,361 | $44.88 | $61.1K | 43,226 | SEC↗ |
| Stapley Marc | Chief Executive Officer, Dir | F Tax w/h | 2026-09-02 | 2026-09-04 | 8,782 | $44.88 | $394.1K | 432,073 | SEC↗ |
| McGuire Annie | EVP, General Counsel | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,215 | $44.88 | $144.3K | 134,414 | SEC↗ |
| Leite John | Global Chief Commercial Off | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,961 | $44.88 | $177.8K | 128,344 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,639 | $44.88 | $163.3K | 146,158 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2026-09-02 | 2026-09-04 | 3,603 | $44.88 | $161.7K | 169,677 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2026-09-01 | 2026-09-03 | 1,864 | $42.97 | $80.1K | 42,718 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2026-09-01 | 2026-09-03 | 1,864 | $42.97 | $80.1K | 42,718 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2026-06-18 | 2026-06-22 | 529 | $53.55 | $28.3K | 15,097 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2026-06-18 | 2026-06-22 | 3,200 | $52.78 | $168.9K | 15,626 | SEC↗ |
| Miller Thomas F. | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 31,100 | SEC↗ |
| Bhanji Muna | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 44,582 | SEC↗ |
| Holstein Jens | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 32,471 | SEC↗ |
| EPSTEIN ROBERT S | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 57,718 | SEC↗ |
| Barr Eliav | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 56,461 | SEC↗ |
| Shafer David Brent | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 31,100 | SEC↗ |
| JONES EVAN/ FA | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 34,634 | SEC↗ |
| EASTHAM KARIN | Director | A Award | 2026-06-11 | 2026-06-15 | 5,272 | — | $0 | 18,826 | SEC↗ |
| Stapley Marc | Chief Executive Officer | M Exercise deriv | 2026-06-04 | 2026-06-04 | 138,051 | — | $0 | 0 | SEC↗ |
| Leite John | Global Chief Commercial Off | S Sale | 2026-06-04 | 2026-06-04 | 13,975 | $50.07 | $699.7K | 132,305 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2026-06-04 | 2026-06-04 | 138,051 | $50.12 | $6.92M | 440,494 | SEC↗ |
| Stapley Marc | Chief Executive Officer | M Exercise | 2026-06-04 | 2026-06-04 | 138,051 | $36.60 | $5.05M | 578,545 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-06-04 | 2026-06-04 | 1,961 | $50.09 | $98.2K | 173,280 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-06-04 | 2026-06-04 | 1,600 | $49.28 | $78.8K | 175,241 | SEC↗ |
| McGuire Annie | EVP, General Counsel | S Sale | 2026-06-04 | 2026-06-04 | 1,400 | $49.31 | $69.0K | 139,016 | SEC↗ |
| McGuire Annie | EVP, General Counsel | S Sale | 2026-06-04 | 2026-06-04 | 1,776 | $50.12 | $89.0K | 137,240 | SEC↗ |
| Leite John | Global Chief Commercial Off | F Tax w/h | 2026-06-02 | 2026-06-04 | 4,059 | $47.80 | $194.0K | 146,280 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2026-06-02 | 2026-06-04 | 9,012 | $47.80 | $430.8K | 440,494 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2026-06-02 | 2026-06-04 | 3,730 | $47.80 | $178.3K | 149,797 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2026-06-02 | 2026-06-04 | 3,693 | $47.80 | $176.5K | 176,841 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2026-06-02 | 2026-06-04 | 1,361 | $47.80 | $65.1K | 44,073 | SEC↗ |
| McGuire Annie | EVP, General Counsel | F Tax w/h | 2026-06-02 | 2026-06-04 | 3,292 | $47.80 | $157.4K | 140,416 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | M Exercise deriv | 2026-05-22 | 2026-05-27 | 24,000 | — | $0 | 0 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | S Sale | 2026-05-22 | 2026-05-27 | 24,000 | $45.40 | $1.09M | 45,434 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | M Exercise | 2026-05-22 | 2026-05-27 | 24,000 | $24.80 | $595.2K | 69,434 | SEC↗ |
| EPSTEIN ROBERT S | Director | S Sale | 2026-05-20 | 2026-05-22 | 10,000 | $44.01 | $440.1K | 52,446 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2026-05-06 | 2026-05-08 | 5,102 | $40.00 | $204.1K | 143,708 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2026-05-06 | 2026-05-08 | 5,102 | $38.05 | $194.1K | 148,810 | SEC↗ |
| Haas Kevin Richard | Chief Dev and Tech Officer | A Award | 2026-04-10 | 2026-04-14 | 44,221 | — | $0 | 44,221 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | A Award | 2026-03-06 | 2026-03-10 | 13,157 | — | $0 | 180,534 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | A Award | 2026-03-06 | 2026-03-10 | 36,181 | — | $0 | 167,377 | SEC↗ |
| Stapley Marc | Chief Executive Officer | A Award | 2026-03-06 | 2026-03-10 | 92,099 | — | $0 | 449,653 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | A Award | 2026-03-06 | 2026-03-10 | 36,181 | — | $0 | 143,761 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | A Award | 2026-03-06 | 2026-03-10 | 6,578 | — | $0 | 150,339 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | A Award | 2026-03-06 | 2026-03-10 | 29,603 | — | $0 | 146,949 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | A Award | 2026-03-06 | 2026-03-10 | 6,578 | — | $0 | 153,527 | SEC↗ |
| McGuire Annie | SVP, General Counsel | A Award | 2026-03-06 | 2026-03-10 | 26,314 | — | $0 | 153,912 | SEC↗ |
| McGuire Annie | SVP, General Counsel | A Award | 2026-03-06 | 2026-03-10 | 32,892 | — | $0 | 127,598 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | A Award | 2026-03-06 | 2026-03-10 | 10,525 | — | $0 | 45,434 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2026-03-04 | 2026-03-06 | 1,664 | $36.34 | $60.5K | 94,706 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2026-03-04 | 2026-03-06 | 4,994 | $35.29 | $176.2K | 96,370 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2026-03-04 | 2026-03-06 | 5,260 | $35.19 | $185.1K | 107,580 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2026-03-04 | 2026-03-06 | 19,244 | $35.56 | $684.3K | 383,833 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2026-03-04 | 2026-03-06 | 26,279 | $36.28 | $953.4K | 357,554 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-03-04 | 2026-03-06 | 4,400 | $35.55 | $156.4K | 145,137 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2026-03-04 | 2026-03-06 | 13,941 | $36.33 | $506.5K | 131,196 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2026-03-02 | 2026-03-04 | 19,455 | $36.01 | $700.6K | 403,077 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2026-03-02 | 2026-03-04 | 6,035 | $36.01 | $217.3K | 130,771 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2026-03-02 | 2026-03-04 | 13,425 | $36.16 | $485.4K | 117,346 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2026-03-02 | 2026-03-04 | 7,517 | $36.01 | $270.7K | 112,840 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2026-03-02 | 2026-03-04 | 7,234 | $36.01 | $260.5K | 149,537 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2026-03-02 | 2026-03-04 | 3,006 | $36.01 | $108.2K | 34,909 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2026-03-02 | 2026-03-04 | 6,902 | $36.01 | $248.5K | 101,364 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2026-02-26 | 2026-03-02 | 10,867 | $38.75 | $421.1K | 108,266 | SEC↗ |
| McGuire Annie | SVP, General Counsel | A Award | 2026-02-26 | 2026-03-02 | 50,999 | — | $0 | 119,133 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | A Award | 2026-02-26 | 2026-03-02 | 71,806 | — | $0 | 161,292 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2026-02-26 | 2026-03-02 | 24,486 | $38.75 | $948.8K | 136,806 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2026-02-26 | 2026-03-02 | 12,049 | $38.75 | $466.9K | 156,771 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | A Award | 2026-02-26 | 2026-03-02 | 59,324 | — | $0 | 168,820 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2026-02-26 | 2026-03-02 | 35,841 | $38.75 | $1.39M | 422,532 | SEC↗ |
| Stapley Marc | Chief Executive Officer | A Award | 2026-02-26 | 2026-03-02 | 139,074 | — | $0 | 458,373 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2026-02-26 | 2026-03-02 | 8,905 | $38.75 | $345.1K | 120,357 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | A Award | 2026-02-26 | 2026-03-02 | 47,149 | — | $0 | 129,262 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-12-16 | 2025-12-17 | 100 | $43.68 | $4.4K | 67,760 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-12-16 | 2025-12-17 | 10,639 | $43.13 | $458.9K | 67,860 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise deriv | 2025-12-05 | 2025-12-08 | 10,000 | — | $0 | 0 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise deriv | 2025-12-05 | 2025-12-08 | 10,000 | — | $0 | 0 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2025-12-05 | 2025-12-08 | 6,392 | $44.52 | $284.6K | 27,162 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2025-12-05 | 2025-12-08 | 12,808 | $45.84 | $587.1K | 14,354 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2025-12-05 | 2025-12-08 | 800 | $46.59 | $37.3K | 13,554 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise | 2025-12-05 | 2025-12-08 | 10,000 | $7.60 | $76.0K | 33,554 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise | 2025-12-05 | 2025-12-08 | 10,000 | $7.94 | $79.4K | 23,554 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2025-12-04 | 2025-12-04 | 1,278 | $47.51 | $60.7K | 82,113 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2025-12-04 | 2025-12-04 | 3,220 | $47.35 | $152.5K | 318,603 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2025-12-04 | 2025-12-04 | 4,448 | $46.90 | $208.6K | 321,823 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2025-12-04 | 2025-12-04 | 8,537 | $46.61 | $397.9K | 114,237 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2025-12-04 | 2025-12-04 | 4,741 | $47.25 | $224.0K | 109,496 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-12-04 | 2025-12-04 | 702 | $47.51 | $33.4K | 78,499 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-12-04 | 2025-12-04 | 720 | $47.10 | $33.9K | 79,201 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2025-12-02 | 2025-12-04 | 1,325 | $46.16 | $61.2K | 37,420 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2025-12-02 | 2025-12-04 | 2,900 | $46.16 | $133.9K | 83,391 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2025-12-02 | 2025-12-04 | 7,914 | $46.16 | $365.3K | 326,271 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2025-12-02 | 2025-12-04 | 3,384 | $46.16 | $156.2K | 122,774 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2025-12-02 | 2025-12-04 | 3,052 | $46.16 | $140.9K | 79,921 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2025-12-02 | 2025-12-04 | 2,955 | $46.16 | $136.4K | 89,486 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2025-11-25 | 2025-11-26 | 1,106 | $50.25 | $55.6K | 29,362 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2025-11-25 | 2025-11-26 | 2,808 | $50.00 | $140.4K | 86,291 | SEC↗ |
| Holstein Jens | Director | S Sale | 2025-11-20 | 2025-11-21 | 1,460 | $43.21 | $63.1K | 27,199 | SEC↗ |
| Holstein Jens | Director | S Sale | 2025-11-20 | 2025-11-21 | 1,491 | $40.95 | $61.1K | 35,708 | SEC↗ |
| Holstein Jens | Director | S Sale | 2025-11-20 | 2025-11-21 | 7,049 | $42.48 | $299.4K | 28,659 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | S Sale | 2025-11-10 | 2025-11-12 | 5,102 | $42.33 | $216.0K | 38,745 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | S Sale | 2025-11-07 | 2025-11-12 | 5,818 | $40.21 | $233.9K | 43,847 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise deriv | 2025-11-05 | 2025-11-07 | 10,000 | — | $0 | 0 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise deriv | 2025-11-05 | 2025-11-07 | 10,000 | — | $0 | 0 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise deriv | 2025-11-05 | 2025-11-07 | 10,000 | — | $0 | 0 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2025-11-05 | 2025-11-07 | 7,000 | $41.00 | $287.0K | 126,158 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2025-11-05 | 2025-11-07 | 9,674 | $40.02 | $387.2K | 13,554 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2025-11-05 | 2025-11-07 | 408 | $41.74 | $17.0K | 73,256 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise | 2025-11-05 | 2025-11-07 | 10,000 | $5.28 | $52.8K | 53,664 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2025-11-05 | 2025-11-07 | 24,296 | $45.73 | $1.11M | 31,125 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2025-11-05 | 2025-11-07 | 5,872 | $45.07 | $264.7K | 55,421 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2025-11-05 | 2025-11-07 | 10,837 | $43.80 | $474.7K | 61,293 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2025-11-05 | 2025-11-07 | 1,126 | $43.03 | $48.5K | 72,130 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2025-11-05 | 2025-11-07 | 657 | $46.38 | $30.5K | 30,468 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise | 2025-11-05 | 2025-11-07 | 10,000 | $7.60 | $76.0K | 73,664 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise | 2025-11-05 | 2025-11-07 | 10,000 | $7.94 | $79.4K | 63,664 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-11-05 | 2025-11-07 | 6,466 | $40.00 | $258.6K | 82,973 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | A Award | 2025-10-28 | 2025-10-30 | 2,886 | — | $0 | 49,665 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2025-10-06 | 2025-10-07 | 8,349 | $36.02 | $300.7K | 92,441 | SEC↗ |
| EPSTEIN ROBERT S | Director | M Exercise deriv | 2025-10-01 | 2025-10-03 | 10,000 | — | $0 | 0 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-10-01 | 2025-10-03 | 2,160 | $35.00 | $75.6K | 89,439 | SEC↗ |
| EPSTEIN ROBERT S | Director | S Sale | 2025-10-01 | 2025-10-03 | 21,473 | $35.08 | $753.3K | 62,446 | SEC↗ |
| EPSTEIN ROBERT S | Director | M Exercise | 2025-10-01 | 2025-10-03 | 10,000 | $7.94 | $79.4K | 83,919 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2025-10-01 | 2025-10-03 | 2,539 | $35.00 | $88.9K | 89,099 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-09-19 | 2025-09-23 | 2,283 | $33.69 | $76.9K | 91,599 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2025-09-04 | 2025-09-08 | 7,667 | $30.41 | $233.2K | 334,185 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,648 | $30.11 | $49.6K | 46,779 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2025-09-02 | 2025-09-04 | 2,902 | $30.11 | $87.4K | 91,638 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2025-09-02 | 2025-09-04 | 2,955 | $30.11 | $89.0K | 100,790 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2025-09-02 | 2025-09-04 | 7,914 | $30.11 | $238.3K | 341,852 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2025-09-02 | 2025-09-04 | 3,507 | $30.11 | $105.6K | 93,882 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2025-09-02 | 2025-09-04 | 5,371 | $30.11 | $161.7K | 133,158 | SEC↗ |
| Shafer David Brent | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 25,828 | SEC↗ |
| Miller Thomas F. | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 25,828 | SEC↗ |
| Bhanji Muna | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 39,310 | SEC↗ |
| Barr Eliav | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 51,189 | SEC↗ |
| EPSTEIN ROBERT S | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 73,919 | SEC↗ |
| JONES EVAN/ FA | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 43,664 | SEC↗ |
| Holstein Jens | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 37,199 | SEC↗ |
| EASTHAM KARIN | Director | A Award | 2025-06-18 | 2025-06-23 | 9,321 | — | $0 | 23,228 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2025-06-13 | 2025-06-17 | 4,589 | $26.67 | $122.4K | 29,989 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2025-06-13 | 2025-06-17 | 4,590 | $26.66 | $122.4K | 13,907 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2025-06-04 | 2025-06-06 | 2,809 | $27.20 | $76.4K | 94,540 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2025-06-02 | 2025-06-04 | 9,399 | $26.74 | $251.3K | 349,237 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2025-06-02 | 2025-06-04 | 2,955 | $26.74 | $79.0K | 103,745 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2025-06-02 | 2025-06-04 | 1,848 | $26.74 | $49.4K | 47,915 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2025-06-02 | 2025-06-04 | 2,900 | $26.74 | $77.5K | 97,349 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2025-06-02 | 2025-06-04 | 5,370 | $26.74 | $143.6K | 138,529 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2025-06-02 | 2025-06-04 | 3,505 | $26.74 | $93.7K | 97,003 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2025-03-07 | 2025-03-10 | 5,011 | $31.96 | $160.2K | 100,249 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2025-03-07 | 2025-03-10 | 2,400 | $31.04 | $74.5K | 105,260 | SEC↗ |
| Stapley Marc | Chief Executive Officer | A Award | 2025-03-06 | 2025-03-10 | 90,601 | — | $0 | 358,636 | SEC↗ |
| McGuire Annie | SVP, General Counsel | A Award | 2025-03-06 | 2025-03-10 | 30,200 | — | $0 | 100,508 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | A Award | 2025-03-06 | 2025-03-10 | 36,240 | — | $0 | 107,660 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | A Award | 2025-03-06 | 2025-03-10 | 30,200 | — | $0 | 143,899 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | A Award | 2025-03-06 | 2025-03-10 | 24,160 | — | $0 | 106,700 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | A Award | 2025-03-06 | 2025-03-10 | 13,288 | — | $0 | 49,763 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2025-03-04 | 2025-03-06 | 1,142 | $33.69 | $38.5K | 70,308 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2025-03-04 | 2025-03-06 | 28,189 | $32.82 | $925.2K | 292,543 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2025-03-04 | 2025-03-06 | 23,414 | $33.91 | $794.0K | 269,129 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2025-03-04 | 2025-03-06 | 1,094 | $34.37 | $37.6K | 268,035 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2025-03-04 | 2025-03-06 | 3,570 | $33.95 | $121.2K | 82,540 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2025-03-04 | 2025-03-06 | 4,467 | $32.86 | $146.8K | 86,110 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2025-03-02 | 2025-03-03 | 8,255 | $34.76 | $286.9K | 71,450 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2025-03-02 | 2025-03-03 | 11,070 | $34.76 | $384.8K | 113,699 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2025-03-02 | 2025-03-03 | 4,301 | $34.76 | $149.5K | 36,475 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2025-03-02 | 2025-03-03 | 6,754 | $34.76 | $234.8K | 90,577 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2025-03-02 | 2025-03-03 | 20,324 | $34.76 | $706.5K | 320,732 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2025-03-02 | 2025-03-03 | 7,650 | $34.76 | $265.9K | 71,420 | SEC↗ |
| McGuire Annie | SVP, General Counsel | A Award | 2025-02-27 | 2025-03-03 | 13,466 | — | $0 | 86,705 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2025-02-27 | 2025-03-03 | 7,000 | $33.84 | $236.9K | 79,705 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | A Award | 2025-02-27 | 2025-03-03 | 23,170 | — | $0 | 136,680 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2025-02-27 | 2025-03-03 | 11,911 | $33.84 | $403.1K | 124,769 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | A Award | 2025-02-27 | 2025-03-03 | 30,589 | — | $0 | 113,003 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2025-02-27 | 2025-03-03 | 15,672 | $33.84 | $530.3K | 97,331 | SEC↗ |
| Stapley Marc | Chief Executive Officer | A Award | 2025-02-27 | 2025-03-03 | 67,277 | — | $0 | 375,329 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2025-02-27 | 2025-03-03 | 34,273 | $33.84 | $1.16M | 341,056 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | A Award | 2025-02-27 | 2025-03-03 | 11,006 | — | $0 | 84,816 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2025-02-27 | 2025-03-03 | 5,746 | $33.84 | $194.4K | 79,070 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2025-02-03 | 2025-02-05 | 527 | $43.85 | $23.1K | 113,510 | SEC↗ |
| EPSTEIN ROBERT S | Director | M Exercise deriv | 2025-01-06 | 2025-01-08 | 20,000 | — | $0 | 0 | SEC↗ |
| EPSTEIN ROBERT S | Director | M Exercise | 2025-01-06 | 2025-01-08 | 20,000 | $8.04 | $160.8K | 64,598 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise deriv | 2025-01-02 | 2025-01-06 | 10,000 | — | $0 | 0 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise | 2025-01-02 | 2025-01-06 | 10,000 | $5.28 | $52.8K | 28,497 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2025-01-02 | 2025-01-06 | 5,309 | $40.12 | $213.0K | 23,188 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2025-01-02 | 2025-01-06 | 4,691 | $40.50 | $190.0K | 18,497 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2024-12-13 | 2024-12-17 | 400 | $44.14 | $17.7K | 307,345 | SEC↗ |
| Stapley Marc | Chief Executive Officer | S Sale | 2024-12-13 | 2024-12-17 | 5,190 | $43.37 | $225.1K | 307,745 | SEC↗ |
| McGuire Annie | SVP, General Counsel | S Sale | 2024-12-04 | 2024-12-06 | 18,699 | $44.02 | $823.1K | 72,869 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | S Sale | 2024-12-04 | 2024-12-06 | 3,934 | $44.09 | $173.5K | 82,414 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | S Sale | 2024-12-03 | 2024-12-04 | 956 | $43.36 | $41.5K | 40,270 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2024-12-03 | 2024-12-04 | 7,000 | $43.23 | $302.6K | 114,037 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2024-12-03 | 2024-12-04 | 1,050 | $43.25 | $45.4K | 73,810 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2024-12-02 | 2024-12-04 | 5,748 | $44.12 | $253.6K | 312,935 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2024-12-02 | 2024-12-04 | 1,087 | $44.12 | $48.0K | 41,226 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | F Tax w/h | 2024-12-02 | 2024-12-04 | 6,738 | $44.12 | $297.3K | 86,348 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2024-12-02 | 2024-12-04 | 3,464 | $44.12 | $152.8K | 121,037 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2024-12-02 | 2024-12-04 | 1,314 | $44.12 | $58.0K | 74,860 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2024-12-02 | 2024-12-04 | 1,918 | $44.12 | $84.6K | 91,568 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | S Sale | 2024-11-27 | 2024-11-29 | 5,032 | $42.89 | $215.8K | 42,313 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2024-11-19 | 2024-11-21 | 10,125 | $38.76 | $392.4K | 18,497 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2024-11-19 | 2024-11-21 | 1,600 | $36.77 | $58.8K | 31,628 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2024-11-19 | 2024-11-21 | 3,006 | $37.77 | $113.5K | 28,622 | SEC↗ |
| EPSTEIN ROBERT S | Director | M Exercise deriv | 2024-11-12 | 2024-11-14 | 15,000 | — | $0 | 20,000 | SEC↗ |
| EPSTEIN ROBERT S | Director | M Exercise | 2024-11-12 | 2024-11-14 | 15,000 | $8.04 | $120.6K | 59,598 | SEC↗ |
| EPSTEIN ROBERT S | Director | S Sale | 2024-11-12 | 2024-11-14 | 15,000 | $38.32 | $574.8K | 44,598 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | S Sale | 2024-11-12 | 2024-11-14 | 15,275 | $38.34 | $585.6K | 124,501 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-09-19 | 2024-09-23 | 5,173 | $35.23 | $182.2K | 0 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2024-09-04 | 2024-09-06 | 5,479 | $29.78 | $163.2K | 76,174 | SEC↗ |
| Shafer David Brent | Director | A Award | 2024-09-03 | 2024-09-04 | 16,507 | — | $0 | 16,507 | SEC↗ |
| Miller Thomas F. | Director | A Award | 2024-09-03 | 2024-09-04 | 16,507 | — | $0 | 16,507 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2024-09-02 | 2024-09-04 | 1,315 | $31.55 | $41.5K | 81,653 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2024-09-02 | 2024-09-04 | 5,748 | $31.55 | $181.3K | 318,683 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2024-09-02 | 2024-09-04 | 1,087 | $31.55 | $34.3K | 47,345 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2024-09-02 | 2024-09-04 | 1,920 | $31.55 | $60.6K | 93,486 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2024-09-02 | 2024-09-04 | 3,464 | $31.55 | $109.3K | 139,776 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise deriv | 2024-08-13 | 2024-08-14 | 8,486 | — | $0 | 0 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-13 | 2024-08-14 | 2,931 | $31.19 | $91.4K | 51,869 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise | 2024-08-13 | 2024-08-14 | 8,486 | $10.41 | $88.3K | 54,800 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-13 | 2024-08-14 | 16,838 | $32.36 | $544.9K | 35,031 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-13 | 2024-08-14 | 912 | $32.77 | $29.9K | 5,173 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-13 | 2024-08-14 | 22,407 | $32.36 | $725.1K | 6,085 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-13 | 2024-08-14 | 3,869 | $31.19 | $120.7K | 28,492 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-13 | 2024-08-14 | 688 | $32.77 | $22.5K | 34,343 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-12 | 2024-08-14 | 99 | $30.01 | $3.0K | 46,314 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-12 | 2024-08-14 | 101 | $30.01 | $3.0K | 32,361 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise deriv | 2024-08-09 | 2024-08-13 | 300 | — | $0 | 8,486 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-09 | 2024-08-13 | 1,032 | $30.03 | $31.0K | 46,413 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise | 2024-08-09 | 2024-08-13 | 300 | $10.41 | $3.1K | 47,445 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-09 | 2024-08-13 | 746 | $30.03 | $22.4K | 32,462 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise deriv | 2024-08-07 | 2024-08-09 | 1,214 | — | $0 | 8,786 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-07 | 2024-08-09 | 5,108 | $30.32 | $154.9K | 45,180 | SEC↗ |
| JONES EVAN/ FA | Director | M Exercise | 2024-08-07 | 2024-08-09 | 1,214 | $10.41 | $12.6K | 50,288 | SEC↗ |
| Holstein Jens | Director | S Sale | 2024-08-07 | 2024-08-09 | 2,500 | $30.00 | $75.0K | 27,878 | SEC↗ |
| Holstein Jens | Director | S Sale | 2024-08-07 | 2024-08-09 | 2,500 | $28.00 | $70.0K | 30,378 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-07 | 2024-08-13 | 3,143 | $30.32 | $95.3K | 47,145 | SEC↗ |
| JONES EVAN/ FA | Director | S Sale | 2024-08-07 | 2024-08-13 | 1,965 | $30.32 | $59.6K | 33,208 | SEC↗ |
| Holstein Jens | Director | S Sale | 2024-07-16 | 2024-07-18 | 2,500 | $25.00 | $62.5K | 32,878 | SEC↗ |
| Holstein Jens | Director | S Sale | 2024-07-16 | 2024-07-18 | 2,500 | $24.00 | $60.0K | 35,378 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | S Sale | 2024-07-16 | 2024-07-18 | 1,277 | $25.00 | $31.9K | 82,968 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2024-07-16 | 2024-07-18 | 7,500 | $25.00 | $187.5K | 33,228 | SEC↗ |
| EASTHAM KARIN | Director | A Award | 2024-06-13 | 2024-06-17 | 11,473 | — | $0 | 40,728 | SEC↗ |
| EPSTEIN ROBERT S | Director | A Award | 2024-06-13 | 2024-06-17 | 11,473 | — | $0 | 44,598 | SEC↗ |
| Bhanji Muna | Director | A Award | 2024-06-13 | 2024-06-17 | 11,473 | — | $0 | 34,578 | SEC↗ |
| Holstein Jens | Director | A Award | 2024-06-13 | 2024-06-17 | 11,473 | — | $0 | 37,878 | SEC↗ |
| Barr Eliav | Director | A Award | 2024-06-13 | 2024-06-17 | 11,473 | — | $0 | 41,868 | SEC↗ |
| JONES EVAN/ FA | Director | A Award | 2024-06-13 | 2024-06-17 | 11,473 | — | $0 | 49,074 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2024-06-11 | 2024-06-13 | 3,870 | $20.59 | $79.7K | 29,255 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2024-06-10 | 2024-06-11 | 3,870 | $20.32 | $78.6K | 23,105 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise deriv | 2024-06-07 | 2024-06-11 | 2,500 | — | $0 | 7,500 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2024-06-07 | 2024-06-11 | 2,500 | $20.97 | $52.4K | 33,125 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise | 2024-06-07 | 2024-06-11 | 2,500 | $10.41 | $26.0K | 35,625 | SEC↗ |
| Wygant Jonathan | VP, Chief Accounting Officer | F Tax w/h | 2024-06-02 | 2024-06-04 | 1,087 | $20.75 | $22.6K | 47,971 | SEC↗ |
| Leite John | Chief Commercial Officer-CLI | F Tax w/h | 2024-06-02 | 2024-06-04 | 1,314 | $20.75 | $27.3K | 84,245 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2024-06-02 | 2024-06-04 | 5,746 | $20.75 | $119.2K | 323,994 | SEC↗ |
| McGuire Annie | SVP, General Counsel | F Tax w/h | 2024-06-02 | 2024-06-04 | 1,919 | $20.75 | $39.8K | 95,406 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2024-06-02 | 2024-06-04 | 3,462 | $20.75 | $71.8K | 143,240 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2024-05-28 | 2024-05-30 | 1,539 | $21.00 | $32.3K | 26,975 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise deriv | 2024-04-01 | 2024-04-02 | 10,000 | $13.19 | $131.9K | 0 | SEC↗ |
| EASTHAM KARIN | Director | M Exercise | 2024-04-01 | 2024-04-02 | 10,000 | $13.19 | $131.9K | 43,125 | SEC↗ |
| EASTHAM KARIN | Director | S Sale | 2024-04-01 | 2024-04-02 | 10,000 | $21.65 | $216.5K | 33,125 | SEC↗ |
| Stapley Marc | Chief Executive Officer | F Tax w/h | 2024-03-15 | 2024-03-19 | 5,971 | $21.10 | $126.0K | 329,740 | SEC↗ |
| Stapley Marc | Chief Executive Officer | A Award | 2024-03-15 | 2024-03-19 | 11,780 | — | $0 | 335,711 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | F Tax w/h | 2024-03-15 | 2024-03-19 | 2,189 | $21.10 | $46.2K | 146,702 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | A Award | 2024-03-15 | 2024-03-19 | 4,318 | — | $0 | 148,891 | SEC↗ |
| Febbo Phillip G. | Chief Scientific & Med Offic | A Award | 2024-03-06 | 2024-03-08 | 39,904 | — | $0 | 93,086 | SEC↗ |
| Chambers Rebecca | Chief Financial Officer | A Award | 2024-03-06 | 2024-03-08 | 59,856 | — | $0 | 144,573 | SEC↗ |